
Injectable HIV drug more effective than daily oral therapy
An injectable treatment for HIV could be more effective than a daily oral therapy, data suggests. Results from the LATITUDE study of Cabenuva (cabotegravir + rilpivirine), a long-acting injectable developed by HIV specialist ViiV Healthcare, show the switch to the injectable reduced risk of virological failure by nearly half compared to… Read More

